Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Pharmathene Inc (PIP) AMEX

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview as of [[ item.timeDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 202,800
  • Shares Outstanding, K 65,590
  • Annual Sales, $ 10,640 K
  • Annual Income, $ -3,440 K
  • 36-Month Beta 2.41
  • Price/Sales 19.06
  • Price/Book 1.54

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.75 +18.18%
on 11/17/16
3.30 -1.52%
on 12/08/16
+0.45 (+16.07%)
since 11/08/16
3-Month
2.64 +23.11%
on 09/09/16
3.30 -1.52%
on 12/08/16
+0.58 (+21.72%)
since 09/08/16
52-Week
1.38 +135.51%
on 12/16/15
3.30 -1.52%
on 12/08/16
+1.69 (+108.33%)
since 12/08/15

Most Recent Stories

More News
PharmAthene Declares $2.91 Special Cash Dividend on Common Stock

PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against anthrax, today announced that its Board of Directors has declared a special one-time cash dividend of...

PharmAthene Receives Final Payment from SIGA of $83.9 Million

PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against anthrax, today received a final payment from SIGA Technologies, Inc. of $83.9 million which fully satisfies...

PharmAthene Reports Third Quarter 2016 Financial and Operational Results

PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against anthrax, today reported its financial and operational results for the third quarter of 2016.

PharmAthene Announces Receipt of Payments from SIGA

PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against anthrax, today announced it has received a series of payments from SIGA Technologies, Inc. totaling $90...

PharmAthene Withdraws Protest Against HHS Over Anthrax Vaccine Bidding Process

PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against anthrax, today announced that after discussions with the Biomedical Advanced Research and Development...

PharmAthene Files Protest Against HHS Over Anthrax Vaccine Bidding Process

PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against anthrax, today filed a formal protest against the Department of Health and Human Services, challenging...

PharmAthene Reports Second Quarter 2016 Financial and Operational Results

PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against anthrax, today reported its financial and operational results for the second quarter of 2016.

Delaware Supreme Court Affirms Chancery Court Ruling in Favor of PharmAthene

PharmAthene, Inc. (NYSE MKT: PIP) announced today that the Delaware Supreme Court affirmed the Delaware Court of Chancery's decision to award PharmAthene lump sum expectation damages for the value of PharmAthene's...

SIGA Announces That Delaware Supreme Court Affirms Court of Chancery Opinion

SIGA Technologies, Inc. a company specializing in the commercialization of solutions for serious unmet medical needs and biothreats, today announced that the Delaware Supreme Court affirmed...

PharmAthene Reports that SIGA has Filed its Reorganization Plan to Exit from Bankruptcy

PharmAthene, Inc. (NYSE MKT: PIP) reported today that SIGA Technologies, Inc. filed with the U.S. Bankruptcy Court for the Southern District of New York a reorganization plan that sets out the terms and...

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More

Business Summary

PharmAthene Inc. is a biodefense company formed to meet the critical needs of the United States by developing biodefense products. PharmAthene is dedicated to the rapid development of important and novel biotherapeutics to address biological pathogens and chemicals that may be used as weapons of bioterror....

See More

Support & Resistance

2nd Resistance Point 3.35
1st Resistance Point 3.30
Last Price 3.25
1st Support Level 3.20
2nd Support Level 3.15

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.